… Firstly, we discussed NLRP3 inflammasome activation in patients with depression and …
the inhibition of NLRP3 inflammasome activation may be a potential therapeutic strategy for …

… the NLRP3 inflammasome pathway and alleviate neuroinflammation. Finally, we will summarize
the novel treatment strategies … therapeutic strategies for the treatment of these diseases. …

… therapeutic strategies against CNS diseases taking advantage of the NLRP3 inflammasome
… and application of the NLRP3 inflammasome inhibitors in the treatment of CNS diseases. …

… between the NLRP3 inflammasome, mitochondrial dysfunction and oxidative stress, and of
their participation in type 2 diabetes physiopathology, therapeutic strategies to combat type 2 …

… Current therapeutic strategies to lessen both oxidative stress and inflammation will be
emphasized. This will be placed in the context of improving the burden of these diabetic …

… Afterward, activated NLRP3 triggers local … NLRP3 inflammasome contributes to PD
pathogenesis, as well as potential therapeutic strategies targeting the NLRP3 inflammasome in PD. …

… NLRP3 inflammasome … NLRP3 inflammasome activation plays a key role in the progression
of MS or EAE. Therefore, targeting the NLRP3 inflammasome might be a therapeutic strategy …

… therapeutic strategies targeting NLRP3 inflammasome to … activation is vital in seeking reliable
and effective therapies against AS. … of NLRP3 inflammasome activation, the role of NLRP3 …

… NLRP3 inflammasome, can be used as a therapeutic target. … P2X7/NLRP3 pathway is a
candidate therapeutic strategy for … can inhibit the NLRP3 inflammasome activation and improve …

… NLRP3 inflammasome complex and its activation in disease, and detail the current therapies
that modulate either the NLRP3 inflammasome … currently a therapeutic strategy for multiple …